ACTIVE

APOTHEEK CHARLOTTE RAES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result214,9 k €+23,5 %over 1 year

Gross margin389,8 k €+1,7 %over 1 year

Equity355,9 k €+0,5 %over 1 year

Workforce2,0 ETP-28,6 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK CHARLOTTE RAES is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Harelbeke. It employs on average 2,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0890.110.602
Incorporation: 15/06/2007
Legal form: Private limited company
Registered office: Overleiestraat 117
8530 Harelbeke · FlandreSee on map
Contributed capital: 150 000,00 €
Latest accounts: 31/12/2025
Average workforce: 2,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (2)

313
31300

Contacts

1 public detail availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 18 filings

Trend over 16 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	389,8 k €	+1.7%	383,4 k €	+27.2%	301,5 k €	-16.7%	361,8 k €	+2.1%	354,4 k €
EBITDA	246,6 k €	+15.3%	213,9 k €	+63.4%	130,9 k €	-27.8%	181,2 k €	-9.8%	200,9 k €
Operating result	219 k €	+17.6%	186,2 k €	+3194%	5,7 k €	-89.7%	55 k €	-28.9%	77,4 k €
Net result	214,9 k €	+23.5%	174 k €	+2115%	-8,6 k €	-142%	20,6 k €	-49.3%	40,7 k €
Balance sheet
Equity	355,9 k €	+0.5%	354,1 k €	+0.1%	353,6 k €	-2.4%	362,3 k €	+4.0%	348,2 k €
Total assets	842,9 k €	+2.6%	821,8 k €	-45.6%	1,5 M €	-6.6%	1,6 M €	-0.8%	1,6 M €
Cash	184,9 k €	-3.3%	191,2 k €	-54.3%	418,1 k €	+14.9%	364 k €	+54.5%	235,7 k €
Debts	486,9 k €	+4.2%	467,4 k €	-59.6%	1,2 M €	-7.8%	1,3 M €	-2.1%	1,3 M €
Other
Workforce	2,0 ETP	-28.6%	2,8 ETP	-6.7%	3,0 ETP	0.0%	3,0 ETP	+7.1%	2,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

CR Pharma

Director · 0779.890.292

Represented by Raes Charlotte

Active

Ended mandates

Guido Decaestecker

Manager · since 15 juin 2007 · until 31 décembre 2009

Ended

Carine Vervaet

Manager

Ended

Carine VERVAET

Director

Ended

Guido Decaestecker

Manager

Ended

Other companies at this address

Overleiestraat 117 8530 Harelbeke

Company	CBE no.
CR Pharma● Active	0779.890.292

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/06/2026	15/07/2025	26/06/2024	31/08/2023	30/09/2022	30/09/2021
General meeting	16/05/2026	21/06/2025	15/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	16/05/2026	01/06/2026	Dutch	PDF
Abridged model	31/12/2024	21/06/2025	15/07/2025	Dutch	PDF
Abridged model	31/12/2023	15/06/2024	26/06/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	31/08/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	30/09/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	30/09/2021	Dutch	PDF
Abridged model	31/12/2019	08/09/2020	02/10/2020	Dutch	PDF
Abridged model	31/12/2018	30/06/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	25/09/2018	Dutch	PDF
Abridged model	31/12/2016	17/06/2017	27/09/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	23/09/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	14/10/2015	Dutch	PDF
Abridged model	31/12/2013	12/07/2014	30/09/2014	Dutch	PDF
Abridged model	31/12/2012	24/08/2013	24/09/2013	Dutch	PDF
Abridged model	31/12/2011	04/08/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2010	30/07/2011	26/08/2011	Dutch	PDF
Abridged model	31/12/2009	19/07/2010	19/08/2010	Dutch	PDF
Abridged model	31/12/2008	20/06/2009	17/07/2009	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

CR Pharma

Director · 0779.890.292

Represented by Raes Charlotte

Active

Ended mandates

Guido Decaestecker

Manager · since 15 juin 2007 · until 31 décembre 2009

Ended

Carine Vervaet

Manager

Ended

Carine VERVAET

Director

Ended

Guido Decaestecker

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/06/2024
BENAMING - MAATSCHAPPELIJKE ZETEL - DIVERSEN - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/07/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/11/2018
MAATSCHAPPELIJKE ZETEL - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares05/08/2013
BENAMING - KAPITAAL - AANDELEN
PDF
Mandates23/03/2010
ONTSLAGEN - BENOEMINGEN
PDF
Other04/10/2007
DIVERSEN
PDF
Other26/06/2007
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025214,9 k €↑
2024
Annual accounts 2024174 k €↑
2023
Annual accounts 2023-8,6 k €↓
2023
Name changeAPOTHEEK CHARLOTTE RAES
2022
Annual accounts 202220,6 k €↓
2021
Annual accounts 202140,7 k €↓
2021
Name changeAPOTHEEK VERHOEST-VERVAET
2018
Annual accounts 201845,4 k €↓
2017
Annual accounts 2017247,3 k €↑
2016
Annual accounts 2016148,5 k €↑
2015
Annual accounts 201582 k €↑
2014
Annual accounts 20141,7 k €↑
2013
Annual accounts 2013-266,7 k €↓
2012
Annual accounts 2012-4,5 k €↑
2011
Annual accounts 2011-20,9 k €↑
2010
Annual accounts 2010-44,8 k €↓
2009
Annual accounts 2009-28 k €↓
2008
Annual accounts 2008-18,4 k €
15/06/2007
IncorporationPrivate limited company

APOTHEEK CHARLOTTE RAES

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline